Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study (Q48089690)

8 February 2018

title

Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study (English)

1 reference

8 February 2018

0 references

0 references

1 reference

irritable bowel syndrome

1 reference

Reuben K Wong

1

1 reference

8 February 2018

Cao Yang

2

1 reference

8 February 2018

Guang-Hui Song

3

1 reference

8 February 2018

Jennie Wong

4

1 reference

8 February 2018

Khek-Yu Ho

5

1 reference

8 February 2018

publication date

5 August 2014

1 reference

8 February 2018

Digestive Diseases and Sciences

published in

1 reference

8 February 2018

volume

60

1 reference

8 February 2018

issue

1

1 reference

8 February 2018

page(s)

186-194

1 reference

8 February 2018

Fortnightly Review: Irritable bowel, irritable body, or irritable brain?

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Abnormal colonic fermentation in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Gastrointestinal melatonin: localization, function, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Drugs targeting functional bowel disorders: lessons from drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Brain functional magnetic resonance imaging of rectal pain and activation of endogenous inhibitory mechanisms in irritable bowel syndrome patient subgroups and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Activating endogenous visceral pain modulation: a comparison of heterotopic stimulation methods in healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Melatonin-immune system relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Sex differences in phase angle of entrainment and melatonin amplitude in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3299-8

Nocturnal secretion of melatonin in patients with upper digestive tract disorders.

21 January 2018

1 reference

12 December 2020

The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress

1 reference

12 December 2020

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

12 December 2020

Rome III: New standard for functional gastrointestinal disorders

1 reference

12 December 2020

Symptomatology, quality of life and economic features of irritable bowel syndrome--the effect of hypnotherapy

1 reference

12 December 2020

Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

1 reference

12 December 2020

Corticotropin-releasing hormone inhibits melatonin secretion in healthy volunteers--a potential link to low-melatonin syndrome in depression?

1 reference

12 December 2020

Functional and biochemical effects on rat lung following instillation of crocidolite and chrysotile asbestos

1 reference

12 December 2020

Is melatonin involved in the irritable bowel syndrome?

1 reference

12 December 2020

Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation

1 reference

12 December 2020

A patient questionnaire to identify bowel disease

1 reference

12 December 2020

10.1007/S10620-014-3299-8

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018